Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000964BKPyvENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS10041604HBVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS10043730HBVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS10048002HBVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS30008442HIVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS30080432HIVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS30076744HIVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS30085412HIVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS30058432HIVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TVIS30058433HIVENSG00000154928.19protein_codingEPHB1YesYes2047P54762
TCGA Plot Options
Drug Information
GeneEPHB1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009441
UniProt IDP54762
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830